2,023 results match your criteria: "National Institute of Oncology.[Affiliation]"

Down syndrome (DS) is a genetic condition where the person is born with an extra chromosome 21. DS is associated with accelerated aging; people with DS are prone to age-related neurological conditions including an early-onset Alzheimer's disease. Using the Dp(17)3Yey/ + mice, which overexpresses a portion of mouse chromosome 17, which encodes for the transsulfuration enzyme cystathionine β-synthase (CBS), we investigated the functional role of the CBS/hydrogen sulfide (HS) pathway in the pathogenesis of neurobehavioral dysfunction in DS.

View Article and Find Full Text PDF

Research autopsy programmes in oncology: shared experience from 14 centres across the world.

J Pathol

June 2024

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

While there is a great clinical need to understand the biology of metastatic cancer in order to treat it more effectively, research is hampered by limited sample availability. Research autopsy programmes can crucially advance the field through synchronous, extensive, and high-volume sample collection. However, it remains an underused strategy in translational research.

View Article and Find Full Text PDF

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.

Cell Death Differ

May 2024

Cell death, inflammation and immunity laboratory, CECAD Cluster of Excellence, University of Cologne, Cologne, 50931, Germany.

The dysregulated immune response and inflammation resulting in severe COVID-19 are still incompletely understood. Having recently determined that aberrant death-ligand-induced cell death can cause lethal inflammation, we hypothesized that this process might also cause or contribute to inflammatory disease and lung failure following SARS-CoV-2 infection. To test this hypothesis, we developed a novel mouse-adapted SARS-CoV-2 model (MA20) that recapitulates key pathological features of COVID-19.

View Article and Find Full Text PDF

Background: Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We used data from the Ovarian Cancer Association Consortium (OCAC), Consortium of Investigators of Modifiers of (CIMBA), UK Biobank (UKBB), and FinnGen to identify novel HGSOC susceptibility loci and develop polygenic scores (PGS).

Methods: We analyzed >22 million variants for 398,238 women.

View Article and Find Full Text PDF

Morbidity and mortality conferences (MMCs) have evolved beyond their traditional educational role to become instrumental in enhancing patient safety. System-based MMCs offer a unique perspective on patient safety by dissecting systemic factors contributing to adverse events. This paper reviews the impact of MMC in managing postoperative bleeding after gastric and pancreatic cancer surgery, within the constraints of limited resources.

View Article and Find Full Text PDF

Mutated genes may lead to cancer development in numerous tissues. While more than 600 cancer-causing genes are known today, some of the most widespread mutations are connected to the RAS gene; RAS mutations are found in approximately 25% of all human tumors. Specifically, KRAS mutations are involved in the three most lethal cancers in the U.

View Article and Find Full Text PDF

Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.

Mod Pathol

May 2024

HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary. Electronic address:

Primary cutaneous follicle center lymphoma (PCFCL) has an excellent prognosis using local treatment, whereas nodal follicular lymphoma (nFL), occasionally presenting with cutaneous spread, often requires systemic therapy. Distinction of the 2 diseases based on histopathology alone might be challenging. Copy number alterations (CNAs) have scarcely been explored on a genome-wide scale in PCFCL; however, they might serve as potential biomarkers during differential diagnosis and risk stratification.

View Article and Find Full Text PDF

Purpose: To analyze late toxicity after very accelerated partial breast irradiation (VAPBI) for low-risk breast cancer.

Materials: Methods: In this retrospective, observational, international multicenter study (HDH F20220713143949), patients with low-risk breast cancer underwent lumpectomy + vAPBI (high-dose rate multicatheter interstitial brachytherapy-MIBT). VAPBI was performed with 4(4x6.

View Article and Find Full Text PDF
Article Synopsis
  • Selenocysteine, a unique selenium-containing amino acid, is critical for the function of certain enzymes called selenoprotein oxidoreductases but has been lost in some mammalian lineages, particularly in glutathione peroxidase 6 (GPX6).
  • The loss of selenocysteine in GPX6 occurred through strong evolutionary changes while also introducing new mutations that altered the enzyme's catalytic properties.
  • This case of adaptive convergence suggests that these modifications led to novel enzymatic functions rather than merely compensating for the loss of selenocysteine, highlighting an interesting aspect of evolution in mammalian selenoproteins.
View Article and Find Full Text PDF

Adenomyoepithelioma represents a rare tumor of the breast characterized by biphasic proliferation of epithelial and myoepithelial cells. Owing to its nonspecific clinical presentation, the rarity, and the morphological pitfalls in differential diagnosis, the diagnosis may be extremely difficult especially on limited samples such as core needle biopsy; thus, the diagnosis is histological, which is confirmed by the specificities of the immunohistochemical analyses. Here we report a case of a 64-year-old female who presented a benign adenomyoepithelioma diagnosed on core needle biopsy, review the clinicopathological features of breast adenomyoepithelioma diagnosed on core needle biopsy, and discuss the useful clues to prompt accurate diagnosis.

View Article and Find Full Text PDF

Versatile roles of cysteine persulfides in tumor biology.

Curr Opin Chem Biol

April 2024

Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, 1122, Hungary; Department of Anatomy and Histology, HUN-REN-UVMB Laboratory of Redox Biology Research Group, University of Veterinary Medicine, Budapest, 1078, Hungary; Chemistry Institute, University of Debrecen, Debrecen, Hajdú-Bihar County, 4012, Hungary. Electronic address:

Rewiring the transsulfuration pathway is recognized as a rapid adaptive metabolic response to environmental conditions in cancer cells to support their increased cysteine demand and to produce Reactive Sulfur Species (RSS) including hydrogen sulfide (HS) and cysteine persulfide. This can directly (via RSS) or indirectly (by supplying Cys) trigger chemical or enzyme catalyzed persulfidation on critical protein cysteine residues to protect them from oxidative damage and to orchestrate protein functions, and thereby contribute to cancer cell plasticity. In this review key aspects of persulfide-mediated biological processes are highlighted and critically discussed in relation to cancer cell survival, bioenergetics, proliferation as well as in tumor angiogenesis, adaptation to hypoxia and oxidative stress, and regulation of epithelial to mesenchymal transition.

View Article and Find Full Text PDF

The Clinical Techniques, Imaging and Endoscopy Assembly is involved in the diagnosis and treatment of several pulmonary diseases, as demonstrated at the 2023 European Respiratory Society (ERS) International Congress in Milan, Italy. From interventional pulmonology, the congress included several exciting results for the use of bronchoscopy in lung cancer, including augmented fluoroscopy, robotic-assisted bronchoscopy and cryobiopsies. In obstructive lung disease, the latest results on bronchoscopic treatment of emphysema with hyperinflation and chronic bronchitis were presented.

View Article and Find Full Text PDF

Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.

Mol Cancer

February 2024

Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Current treatment guidelines refer to small cell lung cancer (SCLC), one of the deadliest human malignancies, as a homogeneous disease. Accordingly, SCLC therapy comprises chemoradiation with or without immunotherapy. Meanwhile, recent studies have made significant advances in subclassifying SCLC based on the elevated expression of the transcription factors ASCL1, NEUROD1, and POU2F3, as well as on certain inflammatory characteristics.

View Article and Find Full Text PDF

A rare case of small cell carcinoma of the ovary, hypercalcemic type.

J Surg Case Rep

February 2024

Department of Pathology of the National Institute of Oncology, Ibn Sina University Hospital Center, Rabat 10100, Morocco.

Small cell carcinoma of ovary, hypercalcemic type (SCCOHT) is an unusual malignant tumor that most commonly affects young women. Unfortunately, it has a very poor prognosis. We describe here an unusual case of a Moroccan young woman with a left ovarian mass and a symptomatic hypercalcemia.

View Article and Find Full Text PDF

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.

World J Surg Oncol

February 2024

Department of Thoracic Surgery; Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, A-1090, Austria.

Background: By being highly involved in the tumor evolution and disease progression of small cell lung cancer (SCLC), Myc family members (C-Myc, L-Myc, and N-Myc) might represent promising targetable molecules. Our aim was to investigate the expression pattern and prognostic relevance of these oncogenic proteins in an international cohort of surgically resected SCLC tumors.

Methods: Clinicopathological data and surgically resected tissue specimens from 104 SCLC patients were collected from two collaborating European institutes.

View Article and Find Full Text PDF

We report piperazine-fused six-membered-cyclic disulfides as redox substrates that unlock best-in-class bioreduction probes for live cell biology, since their self-immolation after reduction is unprecedentedly rapid. We develop scalable, diastereomerically pure, six-step syntheses that access four key - and -piperazine-fused cyclic dichalcogenides without chromatography. Fluorogenic redox probes using the disulfide piperazines are activated >100-fold faster than the prior art monoamines, allowing us to deconvolute reduction and cyclization rates during activation.

View Article and Find Full Text PDF

Multiple bronchial carcinoids associated with Cowden syndrome.

Endocrine

June 2024

Department of Medicine and Oncology, ENETS Center of Excellence, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

Article Synopsis
  • Cowden syndrome (CS) is a rare genetic disorder linked to mutations in the PTEN tumor suppressor gene, increasing the risk of various tumors, including thyroid and breast cancers.
  • A case study highlights a 46-year-old man with a history of testicular seminoma and thyroid cancer who was diagnosed with CS through genetic testing that confirmed a PTEN mutation.
  • This patient also exhibited multiple pulmonary carcinoid tumors, marking him as the first reported case of CS linked to these specific tumors, suggesting CS may predispose individuals to multifocal pulmonary lesions.
View Article and Find Full Text PDF

Chemotherapy is still one of the main therapeutic approaches in cancer therapy. Nevertheless, its poor selectivity causes severe toxic side effects that, together with the development of drug resistance in tumor cells, results in a limitation for its application. Tumor-targeted drug delivery is a possible choice to overcome these drawbacks.

View Article and Find Full Text PDF

Introduction: The National Oncology Institute of Morocco's (NIO) shift to an automated cytotoxic drug preparation system (PHARMODUCT®) has prompted an evaluation of its economic and clinical impacts compared to traditional manual methods.

Methods: A retrospective cost-benefit analysis over six months, extrapolated to annual projections, assessed initial investments, labour, equipment, drugs and consumables. Four commonly used chemotherapy drugs were analyzed, with a focus on the cost implications of drug waste in manual preparation versus the efficiency of vial-sharing in automated methods.

View Article and Find Full Text PDF
Article Synopsis
  • Rectal carcinoma metastasizing to skeletal muscle is uncommon, with only 30 cases reported since 1970.
  • A case study presents a middle-aged man diagnosed with rectal adenocarcinoma three months prior.
  • A subcutaneous mass in his left proximal buttock was identified and confirmed through histological analysis as a metastatic lesion from the original rectal cancer.
View Article and Find Full Text PDF

Background: Pheochromocytomas (PHEOs) are rare catecholamine-secreting adrenal tumors. Approximately 60-90% of bilateral PHEOs are hereditary. We retrospectively analyzed the clinical characteristics of patients with bilateral PHEOs and the morbidity rate (malignancy, tumor recurrence and adrenal insufficiency (AI) rate) related to surgery technique and genetic status of the patients.

View Article and Find Full Text PDF
Article Synopsis
  • The phase 3 ASPEN trial compared the effectiveness of two BTK inhibitors, zanubrutinib and ibrutinib, in treating Waldenström macroglobulinemia, analyzing genetic mutations' impact on treatment response.
  • The study found that patients with mutations in CXCR4 and TP53 had poorer responses and survival rates but those treated with zanubrutinib generally showed better outcomes than those given ibrutinib.
  • Overall, the research indicated that zanubrutinib offers improved clinical outcomes for patients with specific mutations compared to ibrutinib, highlighting the importance of genetic testing in treatment decision-making.
View Article and Find Full Text PDF

Myxopapillary ependymoma, a rare variant of ependymoma, commonly occurs in the conus medullaris or filum terminale. The rarity of these tumors can make their diagnosis and treatment challenging. This case report presents an atypical occurrence of myxopapillary ependymoma within the sacrum in a 68-year-old patient presented with a 3-month history of persistent left-sided low back pain radiating to the legs and fecal dysfunction.

View Article and Find Full Text PDF